Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Respirology (Carlton, Vic.)|November 29, 2022
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitisHiroki Tanahashi, Kakuhiro Yamaguchi, Koji Kurose, et al.
International Journal of Clinical Oncology|September 19, 2019
Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancerYu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|August 10, 2021
Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General AnesthesiaYu Matsumoto, Takeshi Masuda, Tatsuki Takahashi, et al.
Cancer Science|October 26, 2020
Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancerYu Wakabayashi, Takeshi Masuda, Kazunori Fujitaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2011
FIZZ2/RELM-β induction and role in pulmonary fibrosisTianju Liu, Hyun Ah Baek, Hongfeng Yu, et al.
In Vivo (Athens, Greece)|August 29, 2018
Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II StudyKakuhiro Yamaguchi, Takeshi Masuda, Kazunori Fujitaka, et al.
Molecular and Clinical Oncology|October 23, 2018
Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility studyTakeshi Masuda, Masako Watanabe, Kazunori Fujitaka, et al.
Research in Diagnostic and Interventional Imaging|July 30, 2024
Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysisDaisuke Kawahara, Takeshi Masuda, Riku Nishioka, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2021
Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4Hiroki Tanahashi, Kakuhiro Yamaguchi, Tomoko Koura, et al.
Pageof 12